期刊文献+

小剂量肝素对脓毒症的治疗作用研究

Small Dose of Heparin to Sepsis Treatment Action Research
下载PDF
导出
摘要 目的探讨临床上应用小剂量肝素治疗脓毒症患者的疗效。方法以48例为研究对象,随机分两组,对照组患者进行常规性治疗,观察组在对照组治疗的基础上应用小剂量的肝素。每日记录患者各项指标以及28d死亡率对比分析。结果患者各项指标都有明显的变化,28d死亡率无明显的差异。结论小荆量肝素治疗可以明显的减轻患者的病情及炎症反应,有改善肾功能、肺部氧合以及凝血功能,对于生存率的影响不明显。 objective to study the clinical application of small dose of heparin treatment the curative effect of the patients with sepsis. Methods 48 cases as the research object, random divided into two groups, patients in control group routine treatment, observation group in the control group treatment on the basis of application of small dose of hepaiin. The daily record each index patients and 28 d mortality contrast analysis. Results patients each index has obvious changes, 28 d mortality have no obvious difference. Conclusion small dose of heparin treatment can obviously relieve the patient's condition and inflammation, improve kidney function, lung oxygenation and blood clotting, for no obvious impact on survival rate.
作者 汪明星
出处 《医学信息》 2012年第12期80-81,共2页 Journal of Medical Information
关键词 肝素 脓毒症 小剂量 临床分析 heparin Sepsis Small dose Clinical analysis
  • 相关文献

参考文献5

二级参考文献59

  • 1艾宇航,张丽娜,龚华,徐道妙,赵双平,陈江辉.低分子肝素治疗脓毒症的前瞻性临床研究[J].中国危重病急救医学,2005,17(12):736-739. 被引量:43
  • 2何强,陈江华.脓毒症的急性肾损伤[J].中华肾脏病杂志,2006,22(11):655-657. 被引量:38
  • 3林洪远.从KyberSept和OPTIMIST研究失败看肝素治疗脓毒症的潜力[J].中国危重病急救医学,2007,19(3):134-137. 被引量:27
  • 4王美堂,何建,梅冰,姚橹,霍正禄.肝素对急性肺损伤/急性呼吸窘迫综合征的治疗作用[J].中国急救医学,2007,27(5):443-445. 被引量:7
  • 5Kinasewitz GT,Yan SB,Besson B,et al.Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis,regardless of causative micro-organism[ISBCTN74215569].Crit Care,2004,8:R82-90.
  • 6Bone RC,Balk RA,Cerra FB,et al.Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.The ACCP/SCCM Consensus Conference Committee.American College of Chest Physicians/Society of Critical Care Medicine.Chest,1992,101:1644-1655.
  • 7Bernard GR,Vincent JL,Laterre PF,et al.Efficacy and safety of recombinant human activated protein C for severe sepsis.N Engl J Med,2001,344:699-709.
  • 8Monaet X,Lamia B,Anguel N,et al.Rapid and beneficial bemodynamic effects of activated protein C in septic shock patients.Intensive Care Med,2005,31:1573-1576.
  • 9Abraham E,Laterre PF,Garg R,et al.Dretrecogin alfa (activated) for adults with severe sepsis and a low risk of death.N Engl J Meal,2005,353:1332-1341.
  • 10Schippar HG,Jenkins CS,Kahle LH,et al.Antithrombin-Ⅲ transfusion in disseminated intravaseular coagulation.Lancet,1978,1:854-856.

共引文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部